This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
NEW YORK (Reuters Health) – Asymptomatic carotid artery stenosis does not increase the risk of stroke or mortality after coronary artery bypass graft (CABG) surgery, according to a…
NEW YORK (Reuters Health) – The response of adolescents with migraine to treatment with combination sumatriptan and naproxen sodium is similar to that seen in adults, with no…
NEW YORK (Reuters Health) – Deep brain stimulation works well not only for Parkinson’s disease (PD) but also for benign tremulous parkinsonism (BTP) and the effects are long-lasting,…
Brien Smith, MD, Board Chair, Epilepsy Foundation, discusses his lifelong struggle with epilepsy and his rise to becoming Chief of Neurology for the Spectrum Health Medical Group and…
NEW YORK (Reuters Health) – For patients with Alzheimer’s disease, prophylactic treatment with divalproex sodium does not delay the emergence of agitation or psychosis, or slow the progression…
Anthony Geraci, MD, Founder and President, neurOasis, provides an overview of the various treatments for migraine, including a class of medication called triptans and a new drug technology…
Anthony Geraci, MD, Founder and President, neurOasis, discusses the prevalence and hallmarks of migraines and what doctors and patients need to know when diagnosing the condition. A key…
NEW YORK (Reuters Health) – Treatment of isolated diastolic hypertension in patients with cerebrovascular disease protects against major vascular events, according to results from the PROGRESS trial. “For…
NEW YORK (Reuters Health) – When added to whole-brain irradiation, radiosurgery is preferable to neurosurgical resection for treating cancer patients with a single metastasis to the brain, according…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…
